GLP-1 Drugs Linked to Increased Risk of Eye Conditions
Semaglutide and tirzepatide, two popular diabetes medications also used for weight loss, have raised concerns about potential eye complications. Two new studies published today investigated the association between these drugs and serious eye conditions such as non-arteritic anterior ischaemic optic neuropathy (NAION). According to previous research, semaglutide was linked with a four-fold increased risk of … Read more